title: Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
authors.affiliation: Section of Hematology and Oncology, Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, NH 03756, USA.
authors.forename: D L
authors.initials: DL
authors.lastname: Ornstein
authors.forename: P
authors.initials: P
authors.lastname: Ely
mesh_terms: D000284:Administration, Oral; D000380:Agranulocytosis / Q000139:chemically induced*; D000935:Antifungal Agents / Q000009:adverse effects*; D005260:Female; D005533:Foot Dermatoses / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects*; D014009:Onychomycosis / Q000188:drug therapy*; D000077291:Terbinafine
chemical_list: D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine